Ikena Oncology, Inc.IKNANASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
4 yr
Consecutive declineDecelerating
PeriodValue
2025-12.47%
2024-5.00%
202312.27%
202223.24%
2021103.19%
202021.34%
2019152.14%
20180.00%